• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2012-2020 年麻疹和风疹全球战略计划》中期审查。

Measles and Rubella Global Strategic Plan 2012-2020 midterm review.

机构信息

Emory Vaccine Center, Emory University School of Medicine, Atlanta, United States.

The Task Force for Global Health, Atlanta, United States.

出版信息

Vaccine. 2018 Jan 11;36 Suppl 1:A1-A34. doi: 10.1016/j.vaccine.2017.09.026.

DOI:10.1016/j.vaccine.2017.09.026
PMID:29307367
Abstract
  1. Measles eradication is the ultimate goal but it is premature to set a date for its accomplishment. Existing regional elimination goals should be vigorously pursued to enable setting a global target by 2020. 2. The basic strategic approaches articulated in the Global Measles and Rubella Strategic Plan 2012-2020 are valid to achieve the goals but have not been fully implemented (or not appropriately adapted to local situations). 3. The report recommends a shift from primary reliance on supplementary immunization activities (SIAs) to assure two doses of measles-containing vaccine (MCV) are delivered to the target population to primary reliance on ongoing services to assure administration of two doses of MCV. Regular high quality SIAs will still be necessary while ongoing services are being strengthened. 4. The report recommends a shift from primary reliance on coverage to measure progress to incorporating disease incidence as a major indicator. 5. The report recommends that the measles/rubella vaccination program be considered an indicator for the quality of the overall immunization program and that measles/rubella incidence and measles and rubella vaccination coverage be considered as primary indicators of immunization program performance. 6. Polio transition presents both risks and opportunities: risks should be minimized and opportunities maximized. 7. A school entry immunization check could contribute significantly to strengthening overall immunization services with assurance that recommended doses of measles and rubella vaccines as well as other vaccines have been delivered and providing those vaccines at that time if the child is un- or under-vaccinated. 8. Program decisions should increasingly be based on good quality data and appropriate analysis. 9. The incorporation of rubella vaccination into the immunization program needs to be accelerated - it should be accorded equivalent emphasis as measles. 10. Outbreak investigation and response are critical but the most important thing is to prevent outbreaks.
摘要
  1. 消除麻疹是最终目标,但为其设定完成日期还为时过早。应大力追求现有的区域消除目标,以便能够在 2020 年设定全球目标。

  2. 2012-2020 年全球麻疹和风疹战略计划中阐述的基本战略方法对于实现这些目标是有效的,但尚未得到充分实施(或未适当地适应当地情况)。

  3. 该报告建议从主要依赖补充免疫活动(SIAs)转变为确保向目标人群提供两剂含麻疹疫苗(MCV),转而主要依赖正在进行的服务来确保两剂 MCV 的管理。在加强正在进行的服务的同时,仍将需要定期开展高质量的 SIAs。

  4. 该报告建议从主要依赖覆盖率转变为衡量进展情况,将疾病发病率纳入主要指标。

  5. 该报告建议将麻疹/风疹疫苗接种计划视为整个免疫计划质量的指标,并将麻疹/风疹发病率和麻疹和风疹疫苗接种覆盖率视为免疫计划绩效的主要指标。

  6. 脊髓灰质炎过渡既带来风险,也带来机遇:应尽量减少风险,最大限度地利用机会。

  7. 入学免疫检查可以大大有助于加强整体免疫服务,确保已为儿童接种了建议剂量的麻疹和风疹疫苗,如果儿童未接种或接种不足,还可以在此时提供这些疫苗。

  8. 计划决策应越来越基于高质量的数据和适当的分析。

  9. 必须加快将风疹疫苗纳入免疫计划——应给予与麻疹同等的重视。

  10. 暴发调查和应对至关重要,但最重要的是预防暴发。

相似文献

1
Measles and Rubella Global Strategic Plan 2012-2020 midterm review.《2012-2020 年麻疹和风疹全球战略计划》中期审查。
Vaccine. 2018 Jan 11;36 Suppl 1:A1-A34. doi: 10.1016/j.vaccine.2017.09.026.
2
Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.麻疹和风疹全球战略计划 2012-2020 年中期审查报告:背景和摘要。
Vaccine. 2018 Jan 11;36 Suppl 1:A35-A42. doi: 10.1016/j.vaccine.2017.10.065.
3
Strengthening routine immunization through measles-rubella elimination.通过消除麻疹和风疹来加强常规免疫。
Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21.
4
Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.通过横断面网络调查确定加速实现麻疹和风疹消除的研究重点。
Vaccine. 2019 Sep 10;37(38):5745-5753. doi: 10.1016/j.vaccine.2019.02.058. Epub 2019 Mar 18.
5
Progress Toward Measles Elimination - European Region, 2009-2018.迈向消除麻疹的进展 - 欧洲区域,2009-2018 年。
MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):396-401. doi: 10.15585/mmwr.mm6817a4.
6
Progress Toward Measles and Rubella Elimination - India, 2005-2021.迈向消除麻疹和风疹的进展 - 印度,2005-2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1569-1575. doi: 10.15585/mmwr.mm7150a1.
7
The end of measles and congenital rubella: an achievable dream?终结麻疹和先天性风疹:一个可以实现的梦想?
Ann Ig. 2017 Jan-Feb;29(1):1-26. doi: 10.7416/ai.2017.2128.
8
[Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].[西班牙的麻疹和风疹免疫规划及疫苗接种覆盖率。实现消除这两种疾病面临的挑战]
Rev Esp Salud Publica. 2015 Jul-Aug;89(4):357-64. doi: 10.4321/S1135-57272015000400004.
9
Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.建立麻疹和风疹传播模型以支持全球管理政策分析和消除投资案例。
Risk Anal. 2017 Jun;37(6):1109-1131. doi: 10.1111/risa.12831. Epub 2017 May 31.
10
Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.推进强化常规免疫服务,作为消除麻疹和风疹活动的一部分。
Vaccine. 2013 Apr 18;31 Suppl 2:B115-21. doi: 10.1016/j.vaccine.2012.11.094.

引用本文的文献

1
Serological survey to determine measles and rubella immunity gaps across age and geographic locations in The Gambia: a study protocol.在冈比亚开展的血清学调查,以确定不同年龄和地理位置的麻疹和风疹免疫差距:一项研究方案。
Glob Health Action. 2025 Dec;18(1):2540135. doi: 10.1080/16549716.2025.2540135. Epub 2025 Aug 20.
2
[Political support and micro-planning as success factors in a high-quality follow-up vaccination campaign in Ecuador, 2023Apoio político e microplanejamento como fatores de sucesso em uma campanha de vacinação de seguimento de alta qualidade no Equador em 2023].[政治支持与微观规划作为2023年厄瓜多尔高质量后续疫苗接种运动的成功因素,政治支持与微观规划作为2023年厄瓜多尔高质量后续疫苗接种运动的成功因素]
Rev Panam Salud Publica. 2025 Apr 9;49:e32. doi: 10.26633/RPSP.2025.32. eCollection 2025.
3
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.使用麻疹和风疹快速诊断检测来改善病例发现及疫苗接种目标定位。
Vaccines (Basel). 2024 Jul 23;12(8):823. doi: 10.3390/vaccines12080823.
4
Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.使用三种接种策略对赞比亚麻疹零剂量儿童进行疫苗接种成本建模。
Am J Trop Med Hyg. 2024 May 21;111(1):121-128. doi: 10.4269/ajtmh.23-0412. Print 2024 Jul 3.
5
Coverage and determinants of second-dose measles vaccination among under-five children in East Africa countries: a systematic review and meta-analysis.东非国家五岁以下儿童第二剂麻疹疫苗接种的覆盖情况和决定因素:系统评价和荟萃分析。
Front Public Health. 2024 May 1;12:1359572. doi: 10.3389/fpubh.2024.1359572. eCollection 2024.
6
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial.冈比亚的麻疹和风疹疫苗微针贴片:一项 1/2 期、双盲、双模拟、随机、阳性对照、年龄降阶的临床试验。
Lancet. 2024 May 11;403(10439):1879-1892. doi: 10.1016/S0140-6736(24)00532-4. Epub 2024 Apr 29.
7
[Brazilian Ministry of Health strategy to increase vaccination coverage at bordersEstrategia del Ministerio de Salud de Brasil para aumentar las tasas de cobertura de vacunación en las fronteras].[巴西卫生部提高边境地区疫苗接种覆盖率的策略]
Rev Panam Salud Publica. 2024 Apr 29;48:e31. doi: 10.26633/RPSP.2024.31. eCollection 2024.
8
Group-based trajectory models of integrated vaccine delivery and equity in low- and middle-income countries.基于群组的疫苗接种综合轨迹模型与中低收入国家的公平性。
Int J Equity Health. 2024 Jan 9;23(1):5. doi: 10.1186/s12939-023-02088-x.
9
The Impact of the and Legislation in Australia: A Scoping Review.澳大利亚《和法案》的影响:范围综述。
Int J Environ Res Public Health. 2023 Jun 24;20(13):6219. doi: 10.3390/ijerph20136219.
10
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial].一项 1/2 期、单中心、双盲、双模拟、随机、阳性对照、年龄递减试验的研究方案,旨在评估麻疹和风疹减毒活疫苗微针贴片在健康成年人(18 至 40 岁)、麻疹和风疹疫苗初免幼儿(15 至 18 个月)和麻疹和风疹疫苗初免婴儿(9 至 10 个月)中的安全性、耐受性和免疫原性[麻疹和风疹疫苗微针贴片 1/2 期年龄递减试验]。
Trials. 2022 Sep 14;23(1):775. doi: 10.1186/s13063-022-06493-5.